Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects
Status:
Completed
Trial end date:
2017-12-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine what dose of medication administered through a
combined spinal epidural (CSE) provides the optimal pain relief with the minimal amount of
side effects. The 3 doses studied here (1.25, 1.66 and 2.5mg) are routinely use on the labor
floor (depending on the physician preference) but the idea is to quantify safety, efficacy
and side effects for each of these doses.